Breaking News Instant updates and real-time market news.

HSDT

Helius Medical

$2.30

0.28 (13.86%)

06:03
04/16/19
04/16
06:03
04/16/19
06:03

Helius Medical downgraded to Neutral from Buy at BTIG

HSDT Helius Medical
$2.30

0.28 (13.86%)

11/20/18
BTIG
11/20/18
UPGRADE
Target $14
BTIG
Buy
Helius Medical upgraded to Buy from Neutral at BTIG
BTIG analyst Sean Lavin upgraded Helius Medical to Buy from Neutral with a price target of $14. The analyst notes that the company's recent $17.5M stock offering removing the overhang of capital need that was cited in his prior downgrade. Lavin adds that Helius Medical now has the funding to operate until at least the middle of 2019 and sees the stock price retreat from $13 in June to $8 as an opportune time to buy, particularly in light of the recent announcement of the Clinical Experience Programs being in the works at two prestigious U.S. neurorehab centers that validate PoNS therapy.
03/05/19
OPCO
03/05/19
INITIATION
Target $10
OPCO
Outperform
Helius Medical initiated with an Outperform at Oppenheimer
Oppenheimer analyst Steven Lichtman started Helius Medical with an Outperform rating and $10 price target. While FDA approval of the company's Portable Neuromodulation Stimulator device is still pending and market development work remains, the "opportunity ahead is significant," Lichtman tells investors in a research note. He points out that 2.1M people in the U.S. suffer from chronic symptoms of traumatic brain injury with a primary complication of balance or gait disability. The analyst sees 2019 as a key year for Helius as it awaits FDA approval and begins a rollout in Canada.
04/11/19
OPCO
04/11/19
DOWNGRADE
OPCO
Perform
Helius Medical downgraded to Perform from Outperform at Oppenheimer
04/11/19
04/11/19
DOWNGRADE

Perform
Helius Medical downgraded to Perform on FDA PoNS update at Oppenheimer
As previously reported, Oppenheimer analyst Steven Lichtman downgraded Helius Medical to Perform from Outperform following the update on the FDA submission for the company's PoNS, with the agency declining approval and more data needed for resubmission. The next key milestones include the update on U.S. pathway following another expected FDA meeting and potential approvals in Europe/Australia, he contends.

TODAY'S FREE FLY STORIES

BIDU

Baidu

$169.25

-4.09 (-2.36%)

05:56
04/25/19
04/25
05:56
04/25/19
05:56
Hot Stocks
Baidu, Embassy of Switzerland in China sign joint LOI to launch Mini Program »

Baidu signed a Joint…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

TAL

TAL Education

$34.41

-0.59 (-1.69%)

05:54
04/25/19
04/25
05:54
04/25/19
05:54
Earnings
Breaking Earnings news story on TAL Education »

TAL Education sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

TAL

TAL Education

$34.41

-0.59 (-1.69%)

05:53
04/25/19
04/25
05:53
04/25/19
05:53
Earnings
TAL Education reports Q4 EPS 20c, consensus 11c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

HD

Home Depot

$206.70

0.65 (0.32%)

, LOW

Lowe's

$113.98

0.44 (0.39%)

05:51
04/25/19
04/25
05:51
04/25/19
05:51
Recommendations
Home Depot, Lowe's analyst commentary  »

Baird boosts Home Depot,…

HD

Home Depot

$206.70

0.65 (0.32%)

LOW

Lowe's

$113.98

0.44 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 29

    May

AVP

Avon Products

$2.96

0.045 (1.55%)

05:47
04/25/19
04/25
05:47
04/25/19
05:47
Hot Stocks
Avon Products comments on Avon North America transaction »

Avon Products commented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 16

    May

WMT

Walmart

$103.51

0.45 (0.44%)

05:44
04/25/19
04/25
05:44
04/25/19
05:44
Hot Stocks
UK CMA prohibits merger of Walmart subsidiary Asda with Sainsbury's »

The UK Competition and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    May

  • 16

    May

  • 29

    May

  • 05

    Jun

  • 07

    Jun

  • 13

    Nov

UBS

UBS

$13.16

0.07 (0.53%)

05:41
04/25/19
04/25
05:41
04/25/19
05:41
Hot Stocks
UBS sees higher recurring revenues in Global Wealth Management, Asset Management »

UBS provided the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 20

    May

  • 03

    Jun

FB

Facebook

$182.64

-1.13 (-0.61%)

05:38
04/25/19
04/25
05:38
04/25/19
05:38
Recommendations
Facebook price target raised to $215 from $195 at Baird »

Baird analyst Colin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

UBS

UBS

$13.16

0.07 (0.53%)

05:37
04/25/19
04/25
05:37
04/25/19
05:37
Earnings
UBS reports Q1 EPS 30c, consensus 24c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 20

    May

  • 03

    Jun

PYPL

PayPal

$107.18

0.27 (0.25%)

05:35
04/25/19
04/25
05:35
04/25/19
05:35
Recommendations
PayPal analyst commentary at Baird »

PayPal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 14

    May

  • 22

    May

  • 03

    Jun

  • 11

    Jun

NOW

ServiceNow

$242.41

-1.085 (-0.45%)

05:32
04/25/19
04/25
05:32
04/25/19
05:32
Recommendations
ServiceNow analyst commentary  »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    May

CTXS

Citrix

$100.45

-0.4 (-0.40%)

05:29
04/25/19
04/25
05:29
04/25/19
05:29
Recommendations
Citrix analyst commentary  »

Citrix shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$297.12

1.14 (0.39%)

05:27
04/25/19
04/25
05:27
04/25/19
05:27
Recommendations
Align Technology analyst commentary at Piper Jaffray »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 05

    Jun

MSFT

Microsoft

$125.00

-0.5 (-0.40%)

05:24
04/25/19
04/25
05:24
04/25/19
05:24
Recommendations
Microsoft analyst commentary  »

Jefferies boosts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

IRBT

iRobot

$100.39

-30.03 (-23.03%)

05:21
04/25/19
04/25
05:21
04/25/19
05:21
Recommendations
iRobot analyst commentary at Piper Jaffray »

iRobot needs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    Jul

SWI

SolarWinds

$19.77

0.325 (1.67%)

05:17
04/25/19
04/25
05:17
04/25/19
05:17
Recommendations
SolarWinds analyst commentary at Jefferies »

SolarWinds price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

XLNX

Xilinx

$139.79

2.66 (1.94%)

05:15
04/25/19
04/25
05:15
04/25/19
05:15
Downgrade
Xilinx rating change  »

Xilinx downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

SIRI

Sirius XM

$5.71

-0.43 (-7.00%)

05:13
04/25/19
04/25
05:13
04/25/19
05:13
Upgrade
Sirius XM rating change  »

Sirius XM upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

APC

Anadarko

$71.41

7.29 (11.37%)

05:07
04/25/19
04/25
05:07
04/25/19
05:07
Downgrade
Anadarko rating change  »

Anadarko downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 22

    May

CARO

Carolina Financial

$36.91

0.49 (1.35%)

05:06
04/25/19
04/25
05:06
04/25/19
05:06
Earnings
Carolina Financial reports Q1 operating EPS 65c, consensus 69c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

JBAXY

Julius Baer

$0.00

(0.00%)

05:06
04/25/19
04/25
05:06
04/25/19
05:06
Downgrade
Julius Baer rating change  »

Julius Baer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$180.67

-1.66 (-0.91%)

05:04
04/25/19
04/25
05:04
04/25/19
05:04
Upgrade
General Dynamics rating change at JPMorgan »

General Dynamics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 29

    May

NAVI

Navient

$12.96

0.51 (4.10%)

05:03
04/25/19
04/25
05:03
04/25/19
05:03
Upgrade
Navient rating change  »

Navient upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

PTC

PTC

$101.94

1.12 (1.11%)

05:02
04/25/19
04/25
05:02
04/25/19
05:02
Downgrade
PTC rating change  »

PTC downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$8.50

-0.04 (-0.47%)

04:59
04/25/19
04/25
04:59
04/25/19
04:59
Earnings
Deutsche Bank expects Q1 net income EUR 200M, revenue EUR 6.4B »

For the first quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 29

    Apr

  • 03

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.